AlphaGrep UK’s Exponent EXPO Stock Holding History

AlphaGrep UK’s Portfolio EXPO Stock Details EXPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,739	Closed	-$309K	–	799
2026 Q1	$309K	Buy	+4,739	New	+$337K	0.09%	488

Other funds holding EXPO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaGrep UK's EXPO Position: Q2 2026 in Review

AlphaGrep UK sold out of Exponent (EXPO) in Q2 2026, closing a stake of 4,739 shares — an estimated $309K sold.

AlphaGrep UK first reported a position in EXPO in Q1 2026 and held it in 1 quarter. The position peaked at $309K in Q1 2026. 319 funds tracked by Wall St. Rank hold EXPO as of Q2 2026.

AlphaGrep UK reported no remaining Exponent position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 4,739 Exponent shares in Q2 2026, an estimated $309K.
AlphaGrep UK first reported a position in Exponent in Q1 2026 and held it in 1 quarter.
AlphaGrep UK's Exponent position peaked at $309K in Q1 2026.
319 funds tracked by Wall St. Rank held Exponent as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.